Prasugrel Impurity 27 | CAS 88106-31-4 - Request Quote
Prasugrel Impurity 27
| SZ CAT No: | SZ-P024050 |
| CAS No | 88106-31-4 |
| Mol.F. | C7H13Br |
| Mol.Wt. | 177.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Prasugrel Impurity 27 is chemically (1-Bromo-2-methylpropyl)cyclopropane. Prasugrel Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Prasugrel Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Prasugrel.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 88106-31-4
Purchase 88106-31-4
Order 88106-31-4
Enquire 88106-31-4
price of 88106-31-4
88106-31-4 Supplier
88106-31-4 Manufacturer
88106-31-4 Exporter
buy high quality Prasugrel Impurity 27
Purchase Prasugrel Impurity 27
Prasugrel Impurity 27 suppliers
Prasugrel Impurity 27 manufacturers
Prasugrel Impurity 27 price
Order Prasugrel Impurity 27
Enquire Prasugrel Impurity 27
Prasugrel Impurity 27 cost
Prasugrel Impurity 27 Supplier
Prasugrel Impurity 27 Distributor
Prasugrel Impurity 27 for Method Validation
Prasugrel Reference Standard
Prasugrel Impurity 27 for ANDA Filing
Prasugrel Impurity 27 for Forced Degradation Studies
Prasugrel Impurity 27 Identification Standards
Prasugrel Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.